Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(25%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
4
50%
Ph phase_2
3
38%

Phase Distribution

4

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (50.0%)
Phase 23 (37.5%)
N/A1 (12.5%)

Trials by Status

unknown225%
completed225%
terminated113%
not_yet_recruiting113%
recruiting225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8